Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar
Crossref DOI link: https://doi.org/10.1136/rmdopen-2020-001396
Published Online: 2021-01-25
Published Print: 2021-01
Update policy: https://doi.org/10.1136/crossmarkpolicy
Petit, Juliette http://orcid.org/0000-0001-8861-6819
Antignac, Marie
Poilverd, Rose-Marie
Baratto, RĂ©gine
Darthout, Sylvie
Desouches, Sandra
Louati, Karine
Deparis, Nathalie
Berenbaum, Francis
Beauvais, Catherine
Version of Record valid from 2020-11-26